Trial NCT01005914

View at ClinicalTrials.gov 
Org. Study IDs: IRB00004913
Secondary IDs: CDR0000642363 ENZON-OHSU-4913 OHSU-4913

Last trial update was posted on 2023-01-06

MeSH Interventions

Asparaginase Cyclophosphamide Cytarabine Dexamethasone Doxorubicin Imatinib Mesylate Liposomal doxorubicin Methotrexate Methylprednisolone Methylprednisolone Acetate Methylprednisolone Hemisuccinate Pegaspargase Vincristine

MeSH Conditions

Leukemia Leukemia, Lymphoid Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions


Stopping Reasons

Increased rate of bacterial infections

Limitations And Caveats

Study terminated early due to safety concerns. Only one subject completed the study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID